{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Andrikyan W"],"funding":["Bundesministerium für Bildung und Forschung"],"pagination":["829-840"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11862801"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["91(3)"],"pubmed_abstract":["<h4>Aims</h4>Previous work has identified several limitations in \"Summaries of Product Characteristics\" (SmPCs), which are associated with risks for patients. The aim of this study was to evaluate pharmacists' and physicians' interpretation of contraindications in SmPCs and reasons for their nonadherence in clinical routine.<h4>Methods</h4>For 20 commonly missed or ignored absolute contraindications, an anonymous online survey providing 24 clinical example cases (one or two per contraindication) for physicians and pharmacists was developed. Experts in medication safety were asked whether the respective case fulfilled the definition of the contraindication in the SmPC: (a) formally, irrespective of the clinical relevance of the contraindication (17 cases), and (b) whether the contraindicati"],"journal":["British journal of clinical pharmacology"],"pubmed_title":["Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in \"Summaries of Product Characteristics\"."],"pmcid":["PMC11862801"],"funding_grant_id":["01ZZ1910O","01ZZ2320B","01ZZ1910C"],"pubmed_authors":["Maas R","Fromm MF","Sponfeldner MI","Weisbach L","Hartmann M","Farker K","Straubmeier MI","Schuster AK","Andrikyan W","Durr P","Jung-Poppe L"],"additional_accession":[]},"is_claimable":false,"name":"Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in \"Summaries of Product Characteristics\".","description":"<h4>Aims</h4>Previous work has identified several limitations in \"Summaries of Product Characteristics\" (SmPCs), which are associated with risks for patients. The aim of this study was to evaluate pharmacists' and physicians' interpretation of contraindications in SmPCs and reasons for their nonadherence in clinical routine.<h4>Methods</h4>For 20 commonly missed or ignored absolute contraindications, an anonymous online survey providing 24 clinical example cases (one or two per contraindication) for physicians and pharmacists was developed. Experts in medication safety were asked whether the respective case fulfilled the definition of the contraindication in the SmPC: (a) formally, irrespective of the clinical relevance of the contraindication (17 cases), and (b) whether the contraindicati","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2025-04-05T14:38:36.688Z","creation":"2025-04-05T14:38:36.688Z"},"accession":"S-EPMC11862801","cross_references":{"pubmed":["39511858"],"doi":["10.1111/bcp.16331"]}}